KEGG analysis revealed PI3K-Akt signaling, EGFR inhibitor resistance, and other cancer-related pathways (Manning et al., 2002; Caretta and Mucignat-Caretta, 2011; Li et al., 2022). The gene discussed is AKT1; the disease is cancer.